These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 340746)

  • 1. [Studies on the mode of the immunopotentiating action of BCG (Part 1) (author's transl)].
    Harada Y
    Kekkaku; 1977 Oct; 52(10):515-22. PubMed ID: 340746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the mode of the immunopotentiating action of BCG (Part 2) (author's transl)].
    Harada Y
    Kekkaku; 1977 Nov; 52(11):541-7. PubMed ID: 599774
    [No Abstract]   [Full Text] [Related]  

  • 3. Mode of immunopotentiating action of BCG: persistence and spread of BCG infection.
    Ishibashi T; Harada Y; Harada S; Yamada H; Takamoto M; Sugiyama K
    Jpn J Exp Med; 1978 Jun; 48(3):227-32. PubMed ID: 362025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunopotentiating action of BCG and its various effects on tumors (author's transl)].
    Yamada H
    Kekkaku; 1978 Jan; 53(1):11-23. PubMed ID: 633697
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the influence of the methanol extraction residue tubercle bacillus fraction on immunological responsiveness of mice. Effects on antibody formation to a soluble protein and a T-independent antigen, delayed hypersensitivity to sheep erythrocytes and numbers of antigen-reactive lymphoid cells.
    Jacobs DM; Pass E; Abraham C; Weiss DW
    Isr J Med Sci; 1978 Jan; 14(1):60-74. PubMed ID: 75868
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the mode of immunopotentiating action of BCG and wax D. I. Effect on the immune response to SRBC.
    Ishibashi T; Harada Y; Yamada H; Harada S; Takamoto M
    Jpn J Exp Med; 1977 Jun; 47(3):163-8. PubMed ID: 410972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Delayed local reaction (DLR) after BCG vaccination in mice. II.--Correlations with the immune response (author's transl)].
    Lagrange PH; Hurtrel B
    Ann Immunol (Paris); 1978; 129 C(4):547-58. PubMed ID: 697320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.
    Brown CA; Brown IN; Sljivić VS
    Immunology; 1979 Nov; 38(3):481-8. PubMed ID: 391696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction of suppressor adherent cells by injecting heavy dose of live BCG. I. In vitro analysis of suppression of BCG cell wall induced delayed type hypersensitivity (author's transl)].
    Kato K
    Kekkaku; 1980 Sep; 55(9):401-6. PubMed ID: 7431724
    [No Abstract]   [Full Text] [Related]  

  • 10. [Regulation mechanisms of the activity of T lymphocytes : applications to infective and tumoral pathology. II. -- BCG and immuno-stimulation (author's transl)].
    Lagrange P
    Pathol Biol (Paris); 1976 Feb; 24(2):153-9. PubMed ID: 58397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of BCG on antibody producing mouse cells].
    Gryschek G
    Allerg Immunol (Leipz); 1973; 19(2-4):163-5. PubMed ID: 4281617
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of BCG on both cellular and humoral immunity during the early response to a hapten carrier complex.
    Neveu PJ
    Clin Exp Immunol; 1976 Oct; 26(1):169-72. PubMed ID: 63343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy of neoplasms. Part I - Assumptions (author's transl)].
    Szmigiel Z; Skotnicki AB
    Przegl Lek; 1975; 32(5):460-5. PubMed ID: 50612
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of BCG on the production of antibody-forming cells in the primary and secondary immune response against sheep erythrocytes in the mouse].
    Gryschek G
    Acta Biol Med Ger; 1975; 34(1):155-61. PubMed ID: 1101593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A review on mechanism of anti-tumor action of BCG (author's transl)].
    Tokunaga T
    Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
    [No Abstract]   [Full Text] [Related]  

  • 16. [BCG-allergy. Immunological basis and antigen choice (author's transl)].
    Depelchin A
    Acta Tuberc Pneumol Belg; 1974; 64(5):397-412. PubMed ID: 4546123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Macrophage activation by viable BCG in tumor-bearing mice and its relation with delayed hypersensitivity (author's transl)].
    Matsuo K
    Fukuoka Igaku Zasshi; 1979 Aug; 70(8):465-83. PubMed ID: 488891
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental study on local immunochemotherapy].
    Kasuga M; Sakita M; Yamane T; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2113-21. PubMed ID: 6820889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed local reaction (DLR) after BCG vaccination in mice. I.--Description (author's transl].
    Lagrange PH; Hurtrel B; Ravisse P
    Ann Immunol (Paris); 1978; 129 C(4):529-46. PubMed ID: 358908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 3-methylcholanthrene on immune response and thymus weight of Buffalo strain rats.
    Silverman DA; Rose NR
    J Natl Cancer Inst; 1974 Dec; 53(6):1721-4. PubMed ID: 4612165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.